Feb 18, 2020 / NTS GMT
Presentation
Feb 18, 2020 / NTS GMT
=====================
Corporate Participants
=====================
* Brent Andrew Cubis
Cochlear Limited - CFO
* Diggory William Howitt
Cochlear Limited - CEO, MD, President & Executive Director
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
* David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* Hashan De Silva
CLSA Limited, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* Lyanne Harrison
BofA Merrill
Cochlear Ltd
(ASX:COH)
A$
111.61
-0.50 (-0.45%)
Market Cap: 7.30 Bil
Enterprise Value: 7.35 Bil
PE Ratio: 21.16
PB Ratio: 3.77
GF Score: 67/100 Half Year 2020 Cochlear Ltd Earnings Presentation Transcript
Feb 18, 2020 / NTS GMT
Release Date Price:
A$226.62
(-3.39%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot